Results 171 to 180 of about 9,788 (221)
Lectin-type oxidized LDL receptor-1 as a potential therapeutic target for cerebral cavernous malformations treatment. [PDF]
Ashok K +9 more
europepmc +1 more source
Loss of heterozygosity in CCM2 cDNA revealing a structural variant causing multiple cerebral cavernous malformations. [PDF]
Chaussenot A +6 more
europepmc +1 more source
Identifying potential (re)hemorrhage among sporadic cerebral cavernous malformations using machine learning. [PDF]
Li X, Jones P, Zhao M.
europepmc +1 more source
Role of Rho-Associated Kinase in the Pathophysiology of Cerebral Cavernous Malformations. [PDF]
Ayata C +8 more
europepmc +1 more source
Complex Dysautonomia in a Patient With Cerebral Cavernous Malformations Due to a KRIT1 Pleiotropic Gene Mutation. [PDF]
Janssen R +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Pediatric Cerebral Cavernous Malformations
Pediatric Neurology, 2021Cerebral cavernous malformations are the second most common vascular malformations in the central nervous system, and over one-third are found in children. Lesions may be solitary or multiple, be discovered incidentally, be sporadic, or be secondary to familial cavernomatosis or radiation therapy.
Michael Paddock +4 more
openaire +2 more sources

